All studies
RecruitingOBSERVATIONAL

Intent of Surgery for IPMN

This study is reviewing past surgeries for a pancreatic condition called Intraductal Papillary Mucinous Neoplasm (IPMN). Researchers are looking at patient records from 2015 to 2025 to understand why surgery was performed in each case. They want to see how many cancers found within IPMN were unexpected discoveries after surgery. The study also compares patients whose IPMN-related cancers were found during regular check-ups versus those found by chance. Ultimately, the goal is to improve how doctors predict which IPMN cases are more likely to become malignant (cancerous), helping them make better decisions about treatment for future patients.

At a glance

Status
Recruiting
Sponsor
NYU Langone Health
Enrolment target
2,000
Start
15 Sep 2025
Estimated completion
01 Dec 2025

What is this study about?

This research is looking at a condition called Intraductal Papillary Mucinous Neoplasm, or IPMN for short. IPMN is a type of growth that can appear in the pancreas, an organ that helps with digestion and making hormones. While many IPMNs are harmless, some can become cancerous over time. Doctors often recommend surgery for IPMN, but deciding who needs surgery and when can be complex.

This study is a bit like looking through old patient files. Doctors are reviewing records of people in a multi-centre study (meaning it involves several hospitals) who had surgery for IPMN between 2015 and 2025. They want to understand the main reasons why surgery was chosen for each patient. They also want to see how often a cancer related to IPMN was only discovered after surgery, rather than expected beforehand. This helps them understand whether some cancers are being missed or found late.

The researchers will also compare different groups of patients. For example, they'll look at those whose IPMN-related cancer was found during routine check-ups versus those where the cancer was found by chance, perhaps during tests for another problem. By doing this, they hope to get a clearer picture of the warning signs that an IPMN might become serious. Ultimately, the aim is to find better ways to predict which IPMNs are likely to turn cancerous, helping doctors make more accurate decisions for patients in the future about whether surgery is needed.

Key takeaways

  • This study reviews past patient records of IPMN surgery.
  • It aims to understand why surgery was performed and how effectively cancer was detected.
  • The goal is to improve predictions for which IPMNs might become cancerous.
  • It helps doctors make better treatment decisions for future patients.
  • Your direct involvement is not required as it uses existing data.

Who may be eligible?

This study is looking at medical records of people who have already had surgery for a condition called IPMN. To be included, you must have been 18 years old or older at the time of your surgery.

Your surgery must have taken place between 1st July 2015 and 1st July 2025. This includes cases where the IPMN was considered low risk, high risk, or had already become cancerous.

You would not be included in this study if you also had another specific type of pancreatic cancer called concomitant pancreatic ductal adenocarcinoma at the same time as your IPMN.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Were you 18 years old or older when you had your surgery for IPMN?
  2. Did you have surgery for IPMN? (This includes low-risk, high-risk, or cancerous IPMN.)
  3. Did your IPMN surgery happen between 1st July 2015 and 1st July 2025?
  4. Did you NOT also have a different type of pancreatic cancer (called PDAC) at the same time as your IPMN?
Answer every question to see your result.

What does participation involve?

This study is reviewing existing medical records, so you would not need to do anything or attend any extra appointments. There are no new tests, medicines, or follow-up visits involved for patients, as the information is gathered from historical data. Your medical information from your surgery for IPMN would be included as part of the study analysis, if it meets the criteria. This type of study does not involve direct participation from patients once the data has been collected during their treatment.

Potential risks and benefits

Because this study is looking at existing medical records, there are no direct physical risks to you. Your personal information will be kept private and handled with care to protect your identity. The potential benefits are for future patients, as the findings might help doctors better understand IPMN and improve decisions about who needs surgery and when. You would not personally benefit directly from being in the study, and as it's a review of past data, there's no withdrawal process for individual patient participation.

Locations (14)

  • Mayo Clinic
    Verified postcode
    Phoenix, United States· Recruiting
  • Johns Hopkins University
    Verified postcode
    Baltimore, United States· Recruiting
  • Massachusetts General Hospital
    Verified postcode
    Boston, United States· Recruiting
  • Mayo Clinic
    Verified postcode
    Rochester, United States· Recruiting
  • NYU Langone Health
    Verified postcode
    New York, United States· Recruiting
  • Memorial Sloan Kettering
    Verified postcode
    New York, United States· Recruiting
  • Duke University
    Verified postcode
    Durham, United States· Recruiting
  • MD Anderson Cancer Center
    Verified postcode
    Houston, United States· Recruiting
  • Nanjing University
    Verified postcode
    Nanjing, China· Recruiting
  • Heidelberg University
    Verified postcode
    Heidelberg, Germany· Recruiting
  • San Raffaele Hospital
    Verified postcode
    Milan, Italy· Recruiting
  • Padua University
    Verified postcode
    Padua, Italy· Recruiting

Common questions

What is IPMN?

IPMN (Intraductal Papillary Mucinous Neoplasm) is a type of growth in the pancreas, an organ that helps digest food and make hormones. While some are harmless, others can become cancerous.

Will I have to do anything if my records are included?

No, you don't need to do anything. This study is reviewing past medical records, so there are no extra appointments, tests, or treatments for you.

Will my name be shared?

No, your personal information will be kept private. Researchers will look at your medical data but will not share your name or identifying details.

Who is eligible for this study?

This study includes records of people aged 18 or over who had surgery for IPMN between July 2015 and July 2025. It excludes those with a specific other type of pancreatic cancer at the same time.

How will this study help?

The study aims to help doctors better understand IPMN and improve their ability to predict which cases might become serious, leading to better treatment decisions for future patients.

How to find out more

Camila Hidalgo Salinas, MD

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Intent of Surgery for IPMN…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.